Overview
Lobbying Costs
9,999€
Financial year: Apr 2016 - Apr 2017
Lobbyists (Full time equivalent)
0.25 Fte (1)
Lobbyists with EP accreditation
0
High-level Commission meetings
0
Lobbying Costs over the years
-
Info
Mundipharma International Limited
EU Transparency Register
053517422063-07 First registered on 01 Jun 2016
Goals / Remit
Mundipharma and its in network of dependent associated companies are privately owned companies and joint ventures covering the world's pharmaceutical markets.
These companies are committed to bringing to patients the benefits of significant new treatment options.
Mundipharma works with patients, policy-makers at national and EU level, and payers to drive further improvements in treatments across the addiction ecosystem.Main EU files targeted
The network of Mundipharma International Limited associated companies is developing a portfolio of medicines for people living with addiction. Mundipharma International recently responded to the European Commission’s consultation on EU Drugs Strategy.
Address
Head Office
Mundipharma International Limited
Unit 194 Cambridge Science Park
Cambridge CB4 0AB
UNITED KINGDOM -
People
Total lobbyists declared
1
Employment time Lobbyists 25% 1 Lobbyists (Full time equivalent)
0.25
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
None declared
Person in charge of EU relations
Ms Tiffany Wright (Strategic Communications Lead)
Person with legal responsibility
Mr Antony Mattessich (Managing Director)
-
Categories
Category
II - In-house lobbyists and trade/business/professional associations
Subcategory
Companies & groups
-
Networking
Affiliation
None declared
Member organisations
None declared
-
Financial Data
Closed financial year
Apr 2016 - Apr 2017
Lobbying costs for closed financial year
9,999€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
None
ACC
None
Groups (European Parliament)
None
Communication activities
Mundipharma International plans to hold regular meetings with European Commission officials (DG HOME, DG SANTE) and MEPs to discuss the ongoing review of the EU Drugs Strategy and the forthcoming EU Action Plan on Drugs. It also plans to cooperate with MEPs to organise an event at the European Parliament on drug addiction.
Other activities
None declared
Meetings
Meetings
None declared